We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+6.75%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$149M
AUM Growth
+$11.2M
Cap. Flow
+$2.39M
Cap. Flow %
1.6%
Top 10 Hldgs %
23.95%
Holding
173
New
16
Increased
35
Reduced
66
Closed
22

Top Buys

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$783K
2
LHX icon
L3Harris
LHX
+$757K
3
AYI icon
Acuity Brands
AYI
+$739K
4
GILD icon
Gilead Sciences
GILD
+$726K
5
ORCL icon
Oracle
ORCL
+$721K

Sector Composition

Rank Sector Weight
1 Healthcare 19.28%
2 Industrials 16.29%
3 Consumer Staples 15.09%
4 Technology 14.6%
5 Financials 12.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
76
CME Group
CME
$98.9B
$704K 0.47%
3,505
+125
+4% +$25.6K
CRM icon
77
Salesforce
CRM
$210B
$690K 0.46%
4,245
-125
-3% -$19.6K
CRL icon
78
Charles River Laboratories
CRL
$13B
$687K 0.46%
4,500
-2,225
-33% -$308K
CFG icon
79
Citizens Financial Group
CFG
$29.6B
$660K 0.44%
16,245
-200
-1% -$7.49K
ALLY icon
80
Ally Financial
ALLY
$12.6B
$652K 0.44%
21,350
+11,400
+115% +$356K
KNX icon
81
Knight Transportation
KNX
$11.1B
$650K 0.44%
18,150
+10,650
+142% +$391K
PH icon
82
Parker-Hannifin
PH
$117B
$640K 0.43%
3,110
-425
-12% -$82.3K
FTV icon
83
Fortive
FTV
$17B
$637K 0.43%
+13,224
New +$597K
EBAY icon
84
eBay
EBAY
$48.1B
$628K 0.42%
+17,379
New +$630K
CL icon
85
Colgate-Palmolive
CL
$69.4B
$619K 0.41%
8,988
EMR icon
86
Emerson Electric
EMR
$82B
$603K 0.4%
7,908
-275
-3% -$19.8K
IONS icon
87
Ionis Pharmaceuticals
IONS
$7.85B
$577K 0.39%
+9,550
New +$569K
KSU
88
DELISTED
Kansas City Southern
KSU
$568K 0.38%
3,707
WFC icon
89
Wells Fargo
WFC
$271B
$554K 0.37%
10,290
-1,260
-11% -$66K
EA
90
DELISTED
Electronic Arts
EA
$548K 0.37%
5,100
-725
-12% -$72K
AMN icon
91
AMN Healthcare
AMN
$1.32B
$546K 0.37%
8,755
-200
-2% -$11.8K
AMZN icon
92
Amazon
AMZN
$2.68T
$543K 0.36%
5,880
+100
+2% +$8.85K
TMO icon
93
Thermo Fisher Scientific
TMO
$237B
$536K 0.36%
1,650
MS icon
94
Morgan Stanley
MS
$324B
$533K 0.36%
10,425
-950
-8% -$45K
GSK icon
95
GSK
GSK
$100B
$531K 0.36%
9,040
V icon
96
Visa
V
$701B
$528K 0.35%
2,812
-50
-2% -$9.01K
TEX icon
97
Terex
TEX
$6.67B
$518K 0.35%
17,400
-500
-3% -$14.1K
VEEV icon
98
Veeva Systems
VEEV
$43.2B
$513K 0.34%
3,650
+1,850
+103% +$272K
WM icon
99
Waste Management
WM
$86.8B
$513K 0.34%
4,500
+1,050
+30% +$119K
JNPR
100
DELISTED
Juniper Networks
JNPR
$511K 0.34%
20,750
-3,400
-14% -$83.7K

Similar funds

New England Research & Management's Q4 2019 Portfolio in Review

As of Q4 2019, New England Research & Management held 173 positions worth $149M, up 8.1% from $138M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q4 2019 filing shows 16 new, 35 increased, 66 reduced and 22 closed positions. Its largest new stake was Acuity Brands: 5,750 shares worth $794K. The largest sale was Lennar Class A, an estimated $1.06M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Staples.

  • New England Research & Management's largest Q4 2019 buy was Acuity Brands: 5,750 shares worth $794K.
  • New England Research & Management added most to Truist Financial in Q4 2019, an estimated $783K increase.
  • New England Research & Management's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $523K.
  • New England Research & Management fully exited Lennar Class A in Q4 2019, selling an estimated $1.06M.
  • New England Research & Management's ten largest holdings make up 24% of its $149M portfolio in Q4 2019.
  • New England Research & Management opened 16 new positions and closed 22 in Q4 2019.
  • New England Research & Management's portfolio value rose 8.1% quarter-over-quarter to $149M.

Based on New England Research & Management's 13F filing for Q4 2019, filed 14 Jan 2020.